{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T20:10:19Z","timestamp":1690834219434},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["medical-hypotheses.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.mehy.2014.12.019","type":"journal-article","created":{"date-parts":[[2015,1,10]],"date-time":"2015-01-10T22:31:32Z","timestamp":1420929092000},"page":"189-193","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Reduction of Mycobacterium tuberculosis infection in Bacillus Calmette Guerin immunized people is due to training of innate immunity"],"prefix":"10.1016","volume":"84","author":[{"given":"Michael","family":"Eisenhut","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2014.12.019_b0005","unstructured":"WHO (World Health Organization). Global tuberculosis control: WHO report 2011. Geneva: WHO; 2011."},{"key":"10.1016\/j.mehy.2014.12.019_b0010","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2014.12.019_b0015","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.bcp.2010.07.016","article-title":"The protein NOD2: an innate receptor more complex than previously assumed","volume":"80","author":"Lecat","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.mehy.2014.12.019_b0020","doi-asserted-by":"crossref","first-page":"36223","DOI":"10.1074\/jbc.M703079200","article-title":"NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2","volume":"282","author":"Yang","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2014.12.019_b0025","doi-asserted-by":"crossref","first-page":"e1000500","DOI":"10.1371\/journal.ppat.1000500","article-title":"NOD2, PIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis","volume":"5","author":"Pandey","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.mehy.2014.12.019_b0030","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/QCO.0b013e3282f88b5d","article-title":"Mycobacterial interaction with innate receptors: TLRs, C-type lectins, and NLRs","volume":"21","author":"Jo","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.mehy.2014.12.019_b0035","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.coi.2011.06.002","article-title":"A delicate dance: host response to mycobacteria","volume":"23","author":"Huynh","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.mehy.2014.12.019_b0040","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0264-410X(93)90190-9","article-title":"Adjuvants \u2013 a balance between toxicity and adjuvanticity","volume":"11","author":"Gupta","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.mehy.2014.12.019_b0045","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1128\/CMR.7.3.277","article-title":"Molecular adjuvants and immunomodulators: new approaches to immunization","volume":"7","author":"Johnson","year":"1994","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.mehy.2014.12.019_b0050","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/infdis\/153.3.628","article-title":"Clinical evaluation of the immunoadjuvant murabutide, a derivative of MDP, administered with a tetanus toxoid vaccine","volume":"153","author":"Telzak","year":"1986","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.mehy.2014.12.019_b0055","doi-asserted-by":"crossref","first-page":"e41529","DOI":"10.1371\/journal.pone.0041529","article-title":"Intranasal vaccination with murabutide enhances humoral and mucosal immune responses to a virus-like particle vaccine","volume":"7","author":"Jackson","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mehy.2014.12.019_b0060","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.2174\/0929867311320160002","article-title":"Murabutide revisited: a review of its pleiotropic biological effects","volume":"20","author":"Jakopin","year":"2013","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.mehy.2014.12.019_b0065","doi-asserted-by":"crossref","first-page":"g4643","DOI":"10.1136\/bmj.g4643","article-title":"The protective effect of BCG vaccination against Mycobacterium tuberculosis infection in children: a systematic review and meta-analysis","volume":"349","author":"Roy","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.mehy.2014.12.019_b0070","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1164\/rccm.201003-0334OC","article-title":"Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after Bacillus Calmette-Guerin vaccination of newborns","volume":"182","author":"Kagina","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mehy.2014.12.019_b0075","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"PNAS"},{"key":"10.1016\/j.mehy.2014.12.019_b0080","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1128\/CVI.00688-13","article-title":"Trained immunity or tolerance: opposing functional programs induced in human monocytes after engagement of various pattern recognition receptors","volume":"21","author":"Ifrim","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.mehy.2014.12.019_b0085","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nm.2069","article-title":"NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation","volume":"16","author":"Cooney","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.mehy.2014.12.019_b0090","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2249.2011.04381.x","article-title":"Autophagy in the immune response to tuberculosis: clinical perspectives","volume":"164","author":"Ni Cheallaigh","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.mehy.2014.12.019_b0095","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.cell.2004.11.038","article-title":"Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages","volume":"119","author":"Gutierrez","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2014.12.019_b0100","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1073\/pnas.75.10.5142","article-title":"Systemic Bacillus Calmette-Guerin (BCG) activates natural suppressor cells","volume":"75","author":"Bennett","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2014.12.019_b0105","first-page":"367","article-title":"Development of suppressor T cells in mice heavily infected with mycobacteria","volume":"39","author":"Watson","year":"1980","journal-title":"Immunology"},{"key":"10.1016\/j.mehy.2014.12.019_b0110","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.4049\/jimmunol.132.6.2790","article-title":"Suppression of BCG cell wall-induced delayed-type hypersensitivity by pretreatment with killed BCG: induction of nonspecific suppressor T cells by the adjuvant portion (MDP) and of specific suppressor T cells by the antigen portion (TAP)","volume":"132","author":"Kato","year":"1984","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2014.12.019_b0115","first-page":"655","article-title":"Suppression of BCG cell wall-induced delayed-type hypersensitivity by BCG pre-treatment. II. Induction of suppressor T cells by heat-killed BCG injection","volume":"45","author":"Kato","year":"1982","journal-title":"Immunology"},{"key":"10.1016\/j.mehy.2014.12.019_b0120","article-title":"Performance of tuberculin skin test measured against interferon gamma release assay as reference standard in children","volume":"2014","author":"Eisenhut","year":"2014","journal-title":"Tuberc Res Treat"},{"key":"10.1016\/j.mehy.2014.12.019_b0125","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/595847","article-title":"Use of T cell-based diagnosis of tuberculosis infection to optimize interpretation of tuberculin skin testing in child tuberculosis contacts","volume":"48","author":"Bakir","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mehy.2014.12.019_b0130","doi-asserted-by":"crossref","first-page":"8861","DOI":"10.1016\/j.vaccine.2007.10.025","article-title":"The effect of tuberculin skin test and BCG vaccination on the expansion of PPD-specific IFN-gamma producing cells ex vivo","volume":"25","author":"Ota","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.mehy.2014.12.019_b0135","article-title":"The effectiveness of BCG vaccination in preventing Mycobacterium tuberculosis infection and disease in Greenland","volume":"1","author":"Michelsen","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.mehy.2014.12.019_b0140","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1016\/j.vaccine.2009.08.031","article-title":"BCG vaccination reduces risk of infection with Mycobacterium tuberculosis as detected by gamma interferon release assay","volume":"27","author":"Eisenhut","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.mehy.2014.12.019_b0145","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1128\/IAI.62.8.3472-3478.1994","article-title":"Defective antigen presentation by Mycobacterium tuberculosis-infected monocytes","volume":"62","author":"Gercken","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.mehy.2014.12.019_b0150","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1126\/science.8098550","article-title":"Sequestration from immune CD4+ T cells of mycobacteria growing in human macrophages","volume":"260","author":"Pancholi","year":"1993","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.mehy.2014.12.019_b0155","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.tube.2013.11.003","article-title":"A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data","volume":"94","author":"McShane","year":"2014","journal-title":"Tuberculosis"},{"key":"10.1016\/j.mehy.2014.12.019_b0160","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.tube.2011.11.007","article-title":"Ultra-low dose of Mycobacterium tuberculosis aerosol creates partial infection in mice","author":"Saini","year":"2012","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.mehy.2014.12.019_b0165","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/thoraxjnl-2012-202208","article-title":"Lower prevalence of tuberculosis infection in BCG vaccinees: a cross-sectional study in adult prison inmates","volume":"68","author":"Chan","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.mehy.2014.12.019_b0170","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1600-065X.1982.tb01063.x","article-title":"Cloned T lymphocytes and monoclonal antibodies as probes for cell surface molecules active in T cell-mediated cytolysis","volume":"68","author":"Sarmiento","year":"1982","journal-title":"Immuno Rev"},{"key":"10.1016\/j.mehy.2014.12.019_b0175","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.tube.2006.02.001","article-title":"Beneficial non-targeted effects of BCG-ethical implications for the coming introduction of new TB vaccines","volume":"86","author":"Roth","year":"2006","journal-title":"Tuberculosis"},{"key":"10.1016\/j.mehy.2014.12.019_b0180","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.4049\/jimmunol.146.12.4362","article-title":"Estrogen regulates the IFN-gamma promotor","volume":"146","author":"Fox","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2014.12.019_b0185","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1053\/gast.2003.50157","article-title":"TNF-alpha and IFN gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells","volume":"124","author":"Rosenstiel","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mehy.2014.12.019_b0190","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1292\/jvms.68.471","article-title":"Up-regulation of NOD1 and NOD2 through TLR4 and TNF-alpha in LPS-treated murine macrophages","volume":"68","author":"Takahashi","year":"2006","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.mehy.2014.12.019_b0195","doi-asserted-by":"crossref","first-page":"41701","DOI":"10.1074\/jbc.M206473200","article-title":"Induction of NOD2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappaB activation","volume":"277","author":"Gutierrez","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2014.12.019_b0200","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.tube.2006.01.018","article-title":"Immune systems in developed and developing countries; implications for the design of vaccines that will work where BCG does not","volume":"86","author":"Rook","year":"2006","journal-title":"Tuberculosis"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698771500002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698771500002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T19:43:43Z","timestamp":1690832623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030698771500002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S030698771500002X"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2014.12.019","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction of Mycobacterium tuberculosis infection in Bacillus Calmette Guerin immunized people is due to training of innate immunity","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2014.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}